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The sex-limited protein (Slp) antigen of the mouse is first detected in the serum of strain 
DBA/2J males at 5-6 weeks of age and reaches full adult levels by 10 weeks. This antigen 
is normally absent in females. Immature DBA/2J males castrated at 3½ weeks of age 
failed to develop Slp antigen, while DBA/2J females treated with testosterone propionate 
starting at 3½ weeks developed normal adult male levels of Slp antigen. Similar hormone- 
influenced effects were demonstrated in adult males and females of the same strain. 
Experiments indicated that testosterone does not act directly in the serum to expose Slp 
antigenic sites. Testosterone treatment of both males and females of strain C57BL/ 
lOJSf, which does not carry the gene for the presence of the Sip antigen, failed to stimu- 
late the appearance of the antigen. Thus, the presence of Slp antigen in the serum is 
dependent on both the proper genotype and the presence of male hormone. 
INTRODUCTION 
Genetically controlled biochemical variants in mammals may be of particular interest 
and importance where they can be used as tools for exploring interactions between 
specific gene loci and the physiology of the animal. The sex-limited protein (Slp) 
variant of the mouse (Passmore and Shrettter, 1970) provides an unusual opportunity 
for examining the interaction of genetic and hormonal control on the phenotypic 
expression of a serum protein antigen. The sex-limited serum protein variant was dis- 
covered during a search for structural differences in the Ss component of mouse 
serum, which exhibits genetically controlled quantitative variation (Shreffler and 
Owen, 1963; Shreffler, 1967). 
The basic characteristics of  the Slp variant system are: (1) The Slp antigen 
is detected by a specific alloantiserum on agar immunodiffusion. (2) The presence of 
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the antigen in the serum is determined by two alleles at an autosomal locus, with the 
presence of the Slp antigen being determined by a dominant allele (Slpa). The Slp 
antigen is not detectable in the serum of the recessive homozygote (Sip°/Sip°). (3) The 
Slp locus maps within the histocompatibility-2 region in linkage group IX, and in the 
same map position as the genetic determinant for quantitative variation in the Ss 
protein. (4) Immunological evidence indicates that the Slp variant reflects structural 
variation or modification in the Ss protein. (5) The Slp antigen is normally found only 
in mature males of genotypically positive strains, such as DBA/2J and A/J. It is 
absent from males of negative strains (C57BL/10JSf, C3H/JSf, and RF/J) and is 
phenotypically absent from females of all strains. This trait is therefore sex-limited; 
i.e., expression is limited to the male sex. A strain of mice is designated Sip-positive if 
serum from mature males of that strain types positive for the Slp antigen or designated 
Sip-negative if serum from mature males lacks the antigen. The investigations described 
in this report were designed to examine the basis for this sex-limitation, and more 
specifically to determine the effect of male hormone on expression of the Slp antigen. 
A preliminary report of this work has been published (Passmore, 1969). 
M E T H O D S  
Inbred strains of mice were obtained from either the Jackson Laboratory, Bar Harbor, 
Maine (DBA/2J and RF/J), or from our own colony at the University of Michigan 
(C57BL/10JSf, C3H/JSf, and A/Sn). 
All alloimmunizations were carried out according to the procedures of Passmore 
and Shretfler (1970). A pool of RF/J~ anti-DBA/2J~ antiserum was used for all Slp 
typing and quantitation. Rabbit anti-Ss was produced according to the procedure of 
Shreffler and Owen (1963). 
DBA/2J males were castrated at 3½ or 12 weeks of age by making a dorsal incision 
into the peritoneal cavity after anesthetizing with sodium pentabarbital. The testes 
were pulled from the body cavity, ligated at the ductuli efferentes, and excised. The 
sham control consisted of anesthesia, incision, pulling the testes out of the body 
cavity, mild probing, and then replacing the testes in the peritoneal cavity. 
Testosterone propionate (Calbiochem) was injected subcutaneously using sesame 
oil as a carrier. The dosages used were as follows: (1) Animals treated from 3½ to 10 
weeks of age received 1.5 mg of testosterone propionate per week in two injections for 
the first 10 days and then 2.25 mg of hormone per week in three injections for the 
remainder of the treatment period. (2) Animals in which treatment was started at 1 
week of age received gradually increasing doses of testosterone propionate equivalent 
to 0.1 mg/week/gram of body weight in two or three injections per week. This dose is 
equivalent to the adult dose of 2.25 mg per week. (3) Females in which treatment was 
started at 12 weeks of age received 2.25 mg of the hormone per week in three injections. 
(4) An eightfold increased dose of testosterone propionate was used in one experiment, 
consisting of 18.0 mg of hormone per week. 
Immunodiffusion was carried out according to the method described by Passmore 
and Shreffler (1970), with the exception that 8 by 10 cm glass plates, each with 12 ml of 
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agar gel, were used instead of 2.5 by 7.5 em microscope slides. This allowed for more 
typing wells per plate and provided a flatter gel surface. 
The quantity of Slp antigen in individual serum samples was estimated on immuno- 
diffusion plates by measuring the distance from the antigen well to the precipitin line 
and expressing this distance as a percentage of the total distance between the antigen 
and antibody wells, then comparing these R I values with values obtained by standard 
dilutions of the Slp antigen. Since a standard pool of antiserum (RF/J~ anti-DBA/2J~') 
was used in all tests, precipitin band position was solely a function of antigen con- 
centration. The level of the Slp antigen in the castration and hormone treatment studies 
was estimated in this way using a pool of adult DBA/2J male serum (4-8 months of 
age) as the 100% standard. Twenty microliters of antigen or antibody was used in all 
wells. This technique reliably distinguished between twofold serial dilutions, i.e., between 
undiluted antigen and a one-half dilution, between one-half and one-fourth dilutions, 
etc. 
The Ss protein was quantitated by double immunodiffusion in tubes, according to 
the method of Preer (1956) as modified by Shreffler and Steinberg (1967). 
R E S U L T S  
The Slp antigen is first detected in trace amounts in normal DBA/2J male serum at 
5-6 weeks of age, a time which approximately corresponds to the onset of sexual 
maturity. The level of antigen then begins to increase until the adult level is reached at 
about 10 weeks of age. However, immature DBA/2J males which were castrated at 
3½ weeks of age failed to develop Slp antigen and were still negative for the antigen 
when tested after 25 weeks of age (Fig. 1). When these castrated males were then treated 
with testosterone propionate beginning at 25 weeks, Slp antigen was detected 7 days 
after the start of treatment. In sham-operated DBA/2J males, the Slp development was 
normal. Animals which were castrated, but then received replacement therapy with 
testosterone propionate, developed normal levels of Slp at a rate very similar to that of 
untreated males. 
To further test the effect of male hormone on expression of the Slp variant, females 
were treated with testosterone propionate from 3½ to 10 weeks of age. As illustrated 
in Fig. 2, these animals developed normal male levels of Sip by 10 weeks of age. 
Females that were first ovariectomized and then treated with testosterone showed a 
similar appearance of Slp. The slope and shape of these two curves are almost identical 
to those of untreated males in Fig. 1. Control animals which were ovariectomized and 
treated with sesame oil, the carrier for the testosterone propionate, did not develop 
Slp antigen. 
In the preceding experiments, in which treatment of females or castrated males 
was started at 3½ weeks of age, the Sip antigen began to appear at about 5 weeks of 
age. It was of interest to know whether it was possible to make the Slp antigen 
appear earlier in postnatal development by beginning the hormone treatment earlier. 
In an experiment in which hormone treatment was started at 1 week rather than 3½ 
weeks of age, in two litters containing both males and females, the Slp antigen 
appeared again at 5 weeks of age, i.e., no earlier than in the previous experiment 
2 0 4  Passmore and Shre t t l e r  
co 
w I O 0 - -  
._j X - -  --X 
< 







-- x >_ 
I.-- 
o 2 0 - -  < 
m 
~ I I I I I I I ,~ .___1 
4 5 6 7 8 9 I0 v 25 
AGE (WEEKS) 
Fig. 1. The effect of castration on immature DBA/2J males: 
--©-- sham control males (four animals); --zx-- castrated 
(eight animals); --<>-- castrated + testosterone beginning at 3 ½ 
weeks of age (four animals); - - x - -  males+testosterone be- 
ginning at 1 week of age (four animals). 
(see Figs. 1 and 2). These animals developed the antigen at the same rate as animals 
started on testosterone treatment at 31 weeks of  age. 
The failure of castrated males to develop Sip and the ability of females treated with 
testosterone propionate to develop the antigen strongly suggest that male hormone 
triggers the appearance of Sip antigen in genotypically positive strains, such as DBA/ 
2J. Treatment of both males and females of a genetically negative strain such as C57/ 
BL/10JSf with testosterone propionate failed to induce the appearance of Sip antigen. 
Similar studies of the effects of castration and hormone treatment on Sip activity 
were carried out with mature 12-week-old animals. At 12 weeks of age, DBA/2J 
males have already developed full levels of Sip antigen. Males castrated at this age 
showed a sharp reduction in quantitative level of Sip to about 3 0 ~  of the normal adult 
level by 21 days after castration (Fig. 3). After this rapid drop, the level of antigen 
decreased at a much slower rate, reaching 8-10% by 150 days after castration, and by 
200 days failing to a level below the smallest quantity detectable by the immuno- 
diffusion technique (less than 5%). Untreated sham controls maintained 100% Sip 
levels throughout the experiment. Castration of DBA/2J adult males, therefore, 
results in the loss of all detectable amounts of Sip antigen. When two of these castrated 
males were treated with testosterone propionate after 60 days, both showed a return 
to full adult male levels. 
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Fig. 2. The effect of testosterone propionate on immature 
DBA/2J females: --©-- ovariectomized+testosterone 
beginning at 3½ weeks of age (eight animals); --C-- 
females+testosterone beginning at 3½ weeks of age 
(eight animals); --zx-- ovariectomized+sesame oil be- 
ginning at 3½ weeks (four animals); --x--females+ 
testosterone beginning at 1 week of age (four animals). 
The effect of treating mature, 12-week-old DBA/2J females with testosterone 
propionate is shown in Fig. 4. As was the case with immature females, the treatment 
results in the development of full adult levels of Slp. When the hormone treatment was 
suspended after 39 days, the level of Slp antigen declined and was not detectable 80 
days after suspension of treatment. Control females, not treated with hormone, did not 
develop Slp antigen. Females from the genotypically negative strain C57BL/10JSf 
failed to develop Slp antigen when treated with hormone. 
To determine whether increasing the dose of testosterone propionate would 
increase the rate of Slp appearance or the final level of the antigen, a group of adult 
females was treated (starting at 12 weeks of age) with a dose of hormone eightfold 
greater than that used in the previous experiments with adult females. The results of 
this experiment, illustrated in Fig. 4, clearly showed that the 8 x dose did not increase 
the rate of Slp appearance or the final level of the antigen. On the contrary, the final 
level of antigen may have actually been reduced. Four females treated at the same 
time with the normal (1 x)  dose of hormone responded identically to the 1 x dose 
group in Fig. 4. 
The quantitative level of Ss protein was followed in the experiments on immature 
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Fig. 3. The  effect o f  cas t ra t ion  on  ma t u re  DBA/2J  males  (12 weeks o f  age): 
- - ¢ - -  s h a m  cont ro l  males  (four  animals) ;  - - x  - - c a s t r a t ed  at 12 weeks o f  age 
(nine an imals ) ;  - - © -  - males  treated with tes tosterone 60 days after cas t ra t ion  
(two animals) .  
DBA/2J animals (Figs. 1 and 2) to determine whether the development of Slp was 
correlated with any quantitative changes in Ss protein levels. This is of particular 
interest, because the Slp antigenic sites are believed to reflect structural differences in 
the Ss protein of different strains (Passmore and Shretfler, 1970). The quantitative 
level of Ss was approximately the same at 5 weeks of age in all groups of animals. 
At this age, the level was 50-60% of the adult DBA/2J male standard. At 10 weeks of 
age, Ss levels had increased to 80-100% in DBA/2J males, castrated DBA/2J males 
given hormone replacement, and DBA/2J females treated with testosterone. Ss levels 
remained unchanged at 50-60~ in castrated DBA/2J males and normal females. 
Although the three groups showing increased Ss levels all developed Slp antigen, while 
the two groups showing no increase did not develop Slp antigen, similar quantitations 
of an Sip-negative strain, C57BL/10JSf, showed the same pattern of increase in Ss 
levels in normal males and treated females, with no increase in normal females. None 
of these C57BL/10JSf animals developed Slp antigen. Therefore, the increase in Ss 
levels is correlated only with the male hormonal environment and appears to occur in 
both Sip-positive and Sip-negative strains. 
A number of experiments were performed to determine whether the hormone acts 
directly on the DBA/2J female serum to modify the Ss protein so that Slp activity is 
expressed, or whether the hormone triggers some intermediate step which allows for 
the appearance of Slp, e.g., the induction of an enzyme which in turn modifies the Ss 
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Fig. 4. The effect of  testosterone propionate  on  mature  
DBA/2J  females (12 weeks of  age) : - - o - -  ovariectomized + 
testosterone treatment (nine animals); - - 0 - -  females+ 
testosterone (six animals); - - A - -  ovariectomized + sesame 
oil (five animals); - -  x - -  females + eightfold increased dose 
of  testosterone (four animals). 
protein. When DBA/2J female serum was mixed in vitro with testosterone propionate 
or with male serum from the Sip-negative strain C57BL/10JSf, no Slp appeared after 
24 and 48 hr of incubation at either 37 or 25 C. Therefore, no direct modification of 
protein by the hormone could be demonstrated. 
When 0.4 ml of DBA/2J male whole serum was injected intraperitoneally into 
DBA/2J females or into C57BL/10JSf males daily for 8 days, Slp could be detected in 
the serum of the recipient animals for as long as 24 hr after the last injection. This 
would indicate that the Slp antigen is absorbed from the peritoneal cavity into the 
circulation of the recipient animals. Presumably, if testosterone acted directly on the 
Ss protein from Sip-positive strains to produce Slp antigen, the injection of female 
serum from an Sip-positive strain into an Sip-negative male would provide the proper 
environment for modification of the Ss, and therefore for the appearance of Slp 
antigen. However, when DBA/2J female whole serum was injected into C57BL/10JSf 
males using the same 8-day injection schedule, no Slp antigen could be detected 24 hr 
after the last injection. 
The original anti-Slp serum was produced by immunizing RF/J males with Ss 
protein from DBA/2J male serum. The results of a series of alloimmunizations 
involving either female donors or recipients are presented in Table I. Females from the 
Sip-negative strain C3H/JSf were capable of producing anti-Sip when immunized with 
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Table I. Alloimmunizations Involving Female Recipients or Donors 
Strain combination 
Number Number 
Recipient Donor immunized producing anti-Slp 
C3H/JSf ~ A/J ~ 2 2 
C3H/JSf ~ DBA/ZI ~ 2 2 
RF/J ~ DBA/2J ~ 3 0 
RF/J ~ DBA/2J ~ 3 0 
A/Sn ~ A/Sn c~ 3 0 
partially purified A/Sn or DBA/2J male serum. However, the immunization of A/Sn 
females with a serum preparation from A/Sn males produced no antibody, despite 
the fact that the donor was phenotypically positive and the recipient was pheno- 
typically negative. This result would suggest that females from positive strains are 
tolerant to Slp antigen. It is, of course, possible that these females have very low levels 
of Slp antigen or that antigen is present but masked in some way. Partially purified Ss 
protein from DBA/2J females (phenotypically negative but genotypieally positive) did 
not produce anti-Slp in animals of the Sip-negative strain RF/J. If, in fact, DBA/2J 
females have low levels of Sip or masked Slp, it is not of sufficient quantity to elicit an 
immune response in these RF/J animals. 
DISCUSSION 
The castration and hormone treatment experiments with both immature and adult 
animals reveal that both the proper genotype and the presence of male hormone are 
required for the appearance of Slp antigen. Thus, the development of the Slp antigen 
clearly is a result of both genetic and hormonal factors. The disappearance of Slp 
antigen from the sera of castrated males, and from the sera of treated females after 
suspension of treatment, demonstrates that hormone is required for the maintenance 
of the antigen as well as for the triggering of its development. 
Although it is evident that male hormone plays a primary role in the control of 
the phenotypic expression of the Slp variant, the precise mechanism for this control is 
unclear. Some preliminary clues to this mechanism can be discerned from the experi- 
mental results. The discussion which follows will be based on the assumption that the 
Slp variant reflects structural differences in the Ss protein among inbred strains of mice 
(Passmore and Shrettter, 1970). 
Since the genetic studies show the Slp trait to be autosomally inherited, females 
from genotypically Sip-positive strains should have the genetic information necessary 
to code for the variant Ss protein structure. Therefore, in view of the fact that DBA/2J 
females can produce Slp antigen after treatment with testosterone, the absence of Slp 
antigen from the serum of normal untreated females must result from absence of the 
male hormone environment, not from inability to produce the variant protein. 
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Since the time and rate of  appearance of Slp antigen are the same in DBA/2J 
animals, whether hormone treatment is started at 1 week or 3½ weeks of age, it seems 
likely that a differentiation step independent of  the presence of hormone must occur 
during postnatal development before hormone stimulation can be effective. Assuming 
that this hormone-independent differentiation is complete in mature DBA/2J females, 
the minimum lag time necessary to reach detectable levels of  Slp antigen is the period 
of approximately 1 week from the start of  treatment until appearance of Slp antigen 
in the serum of these adult females. Treated immature females develop the antigen at 
5 weeks of age. I f  the lag time is approximately 1 week, then the hormone-independent 
differentiation step must be complete no earlier than 4 weeks of age and treatment 
before this time is ineffective. 
It  would appear possible, a pr ior i ,  that the Ss protein from Sip-positive strains 
could have a basic primary structural difference which makes it susceptible to direct 
modification by male hormone. However, the failure of  Slp to appear after direct 
exposure, either in vivo or in vitro, of DBA/2J female serum to hormone and the 6-8 
day lag period between administration of hormone and appearance of Slp antigen in 
adult females argue against modification of the Ss protein either by hormone or by a 
circulating intermediate, such as an enzyme induced by the hormone. 
Although a great deal of additional work will be necessary to elucidate the precise 
mechanism of hormonal control of  the Slp antigen, the data presented in this report do 
reveal several important facts about the phenomenon: (1) Male hormone is required 
for the development and maintenance of Slp antigen in genotypically positive animals. 
(2) Females of Sip-positive strains have the genetic information necessary to code for 
and produce Slp antigen. (3) There is a differentiation step independent of  male hor- 
mone which must be completed before Slp antigen can develop. (4) Male hormone 
probably does not act directly on Ss protein in the serum to modify it or to expose 
masked Slp antigen sites. 
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